SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-173955
Filing Date
2023-06-23
Accepted
2023-06-23 17:10:56
Documents
1
Group Members
MICHAEL P. RUBINNORTHPOND VENTURES GP, LLCNORTHPOND VENTURES II GP, LLCNORTHPOND VENTURES II, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d526362dsc13da.htm SC 13D/A 94507
  Complete submission text file 0001193125-23-173955.txt   96407
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Subject) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 13D/A | Act: 34 | File No.: 005-92879 | Film No.: 231038637
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7500 OLD GEORGETOWN ROAD SUITE 850 BETHESDA MD 20814
Business Address 7500 OLD GEORGETOWN ROAD SUITE 850 BETHESDA MD 20814 240-800-1200
Northpond Ventures, LP (Filed by) CIK: 0001867472 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A